FRHC vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FRHC exhibits a severe disconnect between its market price and fundamental value, highlighted by a Piotroski F-Score of 4/9 (Stable/Weak) and a Graham Number of $3.2 against a current price of $151.15. The company is currently trading at an astronomical P/E ratio of 7557.50, while reporting negative YoY revenue growth (-14.10%) and dismal profitability metrics (ROE of 0.22%). Despite a positive 5-year price trajectory, recent quarterly earnings have consistently missed estimates with an average surprise of -129.39%, suggesting a bubble-like valuation unsupported by current cash flow or earnings power.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
FRHC vs JPM: Head-to-Head Comparison
This page compares Freedom Holdings Corp. (FRHC) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.